Drug interactions
Carbidopa-levodopa + Methylene blue
Severity: Major
Carbidopa-levodopa and Methylene blue: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Methylene blue is a potent reversible MAO-A inhibitor, and combining it with levodopa, which raises monoamine levels, may precipitate serotonin syndrome or hypertensive reactions. Features include agitation, confusion, hyperthermia, tremor and autonomic instability.
What this interaction means in plain words
Carbidopa-levodopa and Methylene blue can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
MAO-A inhibition by methylene blue reduces catecholamine and serotonin breakdown, adding to the monoamine load from levodopa.
What to do
Avoid the combination where possible; if methylene blue is essential, hold levodopa and monitor closely for serotonin toxicity and blood pressure rises. Resume levodopa after the washout period recommended in the methylene blue labeling.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Carbidopa-levodopa and Methylene blue, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Carbidopa-levodopa
- Carbidopa-levodopa + Isocarboxazid Contraindicated
- Carbidopa-levodopa + Phenelzine Contraindicated
- Carbidopa-levodopa + Selegiline transdermal Contraindicated
- Carbidopa-levodopa + Tranylcypromine Contraindicated
- Amisulpride + Carbidopa-levodopa Major
- Asenapine + Carbidopa-levodopa Major
Frequently asked questions
Can I take Carbidopa-levodopa with Methylene blue?
MediHelp rates the interaction as major. Carbidopa-levodopa and Methylene blue can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Methylene blue is a potent reversible MAO-A inhibitor, and combining it with levodopa, which raises monoamine levels, may precipitate serotonin syndrome or hypertensive reactions. Features include agitation, confusion, hyperthermia, tremor and autonomic instability.
How serious is the interaction between Carbidopa-levodopa and Methylene blue?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible; if methylene blue is essential, hold levodopa and monitor closely for serotonin toxicity and blood pressure rises. Resume levodopa after the washout period recommended in the methylene blue labeling.
What other medicines interact with Carbidopa-levodopa?
MediHelp also lists interactions of Carbidopa-levodopa with, for example, Isocarboxazid, Phenelzine, Selegiline transdermal. The full list is on the Carbidopa-levodopa page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
